• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II EXTENSION CUFF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II EXTENSION CUFF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETEW2020C82E
Medical Device Problem Codes Defective Component (2292); Positioning Problem (3009)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/16/2025
Type of Reportable Event Malfunction
Event or Problem Description
An endurant etew2020c82e lilac extension was implanted in the endovascular treatment of a ulcer.It was confirmed the device was pre pped and opened in the standard fashion.Percutaneous access was established and the device was loaded on the wire and advanced to access site bareback.The device would not enter the artery and was stuck at the access site.The device was removed and a 16fr sheath was used to deliver and deploy the stent graft.The cause of the difficulty inserting the device was found to be a 3-5mm gap between the tapered tip and graft cover which caused a lip which led to the device getting stuck at the access site.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Film evaluation summary: the reported positioning difficulties and gap between the delivery system tip and graft cover could not be confirmed from the limited still images available, therefore, the cause of the events could not be determined.Complete pre-implant cts were not available for review and the provided images did not depict the access vessels.Procedural angiograms showing the advancement attempts were also not available for assessment of the reported events.Device photo evaluation summary: one (1) image received from the account confirmed deformation to the graft cover tip material which is raised and partially bunched.A gap is visible between the taper tip nose cone and the graft cover tip.The reported positioning difficulties leading to deformation in-vivo are confirmed through image review.B5; additional information received: it was reported that the patient had a pre-operative rupture attributed to an ulcerated plaque.The patient had no known history of ulcers.The access vessel was clear and had 9-10mm in diameter.There was no damage noted to the device's box and it was sealed.The gap between the tip and graft cover was noticed after the device was removed from the patient after failed insertion.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II EXTENSION CUFF
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key21399971
Report Number9612164-2025-00824
Device Sequence Number12815674
Product Code MIH
UDI-Device Identifier00613994991393
UDI-Public00613994991393
Combination Product (Y/N)N
Initial Reporter StatePA
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberETEW2020C82E
Device Catalogue NumberETEW2020C82E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/16/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/16/2025
Supplement Date Received by Manufacturer02/18/2025
Initial Report FDA Received Date02/18/2025
Supplement Report FDA Received Date03/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/25/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age85 YR
Patient SexMale
Patient Weight66 KG
-
-